Role of CD14 in human disease
Immunology · 2023-07 · 169 (3) · 260-270
DOI: 10.1111/imm.13634 ↗At a glance
Übersichtsarbeit in Immunology, published online on 2023-03-27. Written by Daniel Sharygin and 4 co-authors. Institution: Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: Endothelial Cells, Toll-Like Receptor 4. Cited 139 times so far (Crossref); 123 references. The full text is freely available in PubMed Central. Funded by: BLRD VA, NIGMS NIH HHS, National Institutes of Health.
Abstract (original language)
The cell surface antigen CD14 is primarily understood to act as a co‐receptor for toll‐like receptors (TLRs) to activate innate immunity responses to pathogens and tissue injury in macrophages and monocytes. However, roles for CD14 are increasingly being uncovered in disease responses in epithelial and endothelial cells. Consistent with these broader functions, CD14 expression is altered in a variety of non‐immune cell types in response to a several of disease states. Moreover, soluble CD14 activated by factors from both pathogens and tissue damage may initiate signalling in a variety of non‐immune cells. This review examined the current understanding CD14 in innate immunity as well as its potential functions in nonimmune cells and associated human diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
- Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID profiles: Tewfik Hamidi
Funding
- BLRD VA
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Cite
APA
Sharygin, D., Koniaris, L. G., Wells, C., Zimmers, T. A., & Hamidi, T. (2023). Role of CD14 in human disease. Immunology, 169(3), 260-270. https://doi.org/10.1111/imm.13634
Vancouver
Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology. 2023;169(3):260-270. doi:10.1111/imm.13634
BibTeX
@article{Sharygin2023,
author = {Sharygin, Daniel and Koniaris, Leonidas G and Wells, Clark and Zimmers, Teresa A and Hamidi, Tewfik},
title = {Role of CD14 in human disease},
journal = {Immunology},
year = {2023},
volume = {169},
number = {3},
pages = {260--270},
doi = {10.1111/imm.13634}
}
EUVIMED